{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:13:33Z","timestamp":1786374813758,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.2459\/jcm.0b013e328341024f","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T23:55:33Z","timestamp":1288742133000},"page":"318-321","source":"Crossref","is-referenced-by-count":18,"title":["Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction"],"prefix":"10.2459","volume":"12","author":[{"given":"Anna","family":"Toso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Leoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Maioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Gallopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delio","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bellandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210207","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/eurheartj\/ehi173","article-title":"Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study","volume":"26","author":"Cavallini","year":"2005","journal-title":"Eur Heart J"},{"key":"R2-5-20210207","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.amjcard.2009.06.032","article-title":"Relation of troponin I levels following non emergent percutaneous intervention to short and long-term outcomes","volume":"104","author":"Feldmann","year":"2009","journal-title":"Am J Cardiol"},{"key":"R3-5-20210207","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","article-title":"Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study","volume":"110","author":"Pasceri","year":"2004","journal-title":"Circulation"},{"key":"R4-5-20210207","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jacc.2009.07.005","article-title":"Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction","volume":"54","author":"Briguori","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R5-5-20210207","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehi455","article-title":"Peri-procedural myocardial injury: 2005 update","volume":"26","author":"Herrmann","year":"2005","journal-title":"Eur Heart J"},{"key":"R6-5-20210207","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amjcard.2009.09.026","article-title":"Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease","volume":"105","author":"Toso","year":"2010","journal-title":"Am J Cardiol"},{"key":"R7-5-20210207","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"Suppl 1","key":"R8-5-20210207","first-page":"51","article-title":"K\/DOQJ clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R9-5-20210207","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.CIR.101.2.125","article-title":"Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs","volume":"101","author":"Gibson","year":"2000","journal-title":"Circulation"},{"key":"R10-5-20210207","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"R11-5-20210207","doi-asserted-by":"crossref","first-page":"401.e9","DOI":"10.1016\/j.ahj.2005.06.006","article-title":"Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study","volume":"150","author":"Leoncini","year":"2005","journal-title":"Am Heart J"},{"key":"R12-5-20210207","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999","volume":"16","author":"Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R13-5-20210207","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.amjcard.2009.06.049","article-title":"A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure","volume":"104","author":"Park","year":"2009","journal-title":"Am J Cardiol"},{"key":"R14-5-20210207","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/01.mol.0000191913.16321.60","article-title":"Clinical implications for statin pleiotropy","volume":"16","author":"Liao","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"R15-5-20210207","first-page":"611","article-title":"Are pleiotropic effects of statins real?","volume":"3","author":"Corsini","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"R16-5-20210207","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199502233320802","article-title":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion","volume":"332","author":"Anderson","year":"1995","journal-title":"N Engl J Med"},{"key":"R17-5-20210207","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collage content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques. Implication for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"R18-5-20210207","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jacc.2006.06.061","article-title":"Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy","volume":"48","author":"Patti","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R19-5-20210207","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury","volume":"51","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R20-5-20210207","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: executive summary","volume":"28","author":"Graham","year":"2007","journal-title":"Eur Heart J"},{"key":"R21-5-20210207","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.amjcard.2007.08.030","article-title":"Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention","volume":"101","author":"Patti","year":"2008","journal-title":"Am J Cardiol"},{"key":"R22-5-20210207","doi-asserted-by":"crossref","first-page":"499e1","DOI":"10.1016\/j.ahj.2007.11.042","article-title":"Prevention of radiocontrast-medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency underogoing coronary angiography (PROMISS) trial: a randomized controlled study","volume":"155","author":"Jo","year":"2008","journal-title":"Am Heart J"},{"key":"R23-5-20210207","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.jacc.2009.08.014","article-title":"High-dose statins prior to percutaneous coronary intervention: a paradigm shift to influence clinical outcomes in the cardiac catheterization laboratory","volume":"54","author":"Tsimikas","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R24-5-20210207","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/ajkd.2003.50140","article-title":"A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease","volume":"41","author":"Bianchi","year":"2003","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01244665-201105000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:18:38Z","timestamp":1786371518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01244665-201105000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2459\/jcm.0b013e328341024f","relation":{},"ISSN":["1558-2027"],"issn-type":[{"value":"1558-2027","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}